Utilization of prospective, pharmacist-driven restriction criteria to improve appropriateness of empiric intravenous vancomycin use
Kinsey McClure Johannemann, Mark Jumper, Blain Thayer, Djeunou Tchamba · 2026
Read Utilization of prospective, pharmacist-driven restriction criteria to improve appropriateness of empiric intravenous vancomycin use by Kinsey McClure Johannemann, Mark Jumper, Blain Thayer, Djeunou Tchamba (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13419411.txt.
Description
Kinsey McClure Johannemann and colleagues test a pharmacist-led rule that screens every starting order for IV vancomycin, a strong antibiotic often begun on suspicion alone. The quasi-experimental study compares matched winter periods, January to March 2024 against the same months in 2025, across sites in one health system. Chart review covered 200 patients, split evenly between the two periods.
Appropriate starting orders jumped from 55 percent before the rule to 97 percent after it took effect, a firm statistical gain. Use totals and blood level checks per patient days were tracked as side measures. Death rates within 30 days did not shift between periods, suggesting tighter control cost no safety. The authors present the rule as a practical model for other hospitals fighting antibiotic overuse.
Catalog record
| CREATOR | Kinsey McClure Johannemann, Mark Jumper, Blain Thayer, Djeunou Tchamba |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28739 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |